Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 3, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on September 28, 2006, where 16,122 Ordinary shares were transferred from the SmithKline Beecham Employee Benefit Trust to a participant in the GlaxoSmithKline Annual Investment Plan. This transaction was notified to the Company on October 2, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the Trust is a discretionary fund for non-US employees and former employees, and that Director Mr. J Heslop holds an interest in the fund similar to other beneficiaries.
Investor Verification Points
- Verify the total number of shares held by the SmithKline Beecham Employee Benefit Trust following the transfer of 16,122 shares.
- Confirm the specific identity of the Annual Investment Plan participant receiving the shares, if disclosed in other records.
- Review the full Disclosure Rule 3.1.4R(1)(b) requirements to ensure complete compliance regarding the Director's interest.